Sign in
Companies / PODD vs BAX

PODD vs BAX: Insulet and Baxter International

Medical Devices
Compare more companies

Insulet (PODD) reported $2.7B in revenue against a 9.1% net margin, while Baxter International (BAX) reported $11.2B at a -8.5% net margin, most recently.

MetricPODDBAX
Revenue$2.7B$11.2B
Net Income$0.2B$-1.0B
Gross Margin71.6%30.1%
Operating Margin17.5%-2.7%
EPS (Diluted)$3.48$-1.87
Free Cash Flow$0.4B$0.3B
Total Debt$0.9B$9.5B
P/E Ratio81.7×n/m
P/B Ratio13.2×n/m
Stock Price$153.92$25.64
Free: last 5 years
Fiscal yearFY2009 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2015 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2020 🔒FY2021FY2022FY2023FY2024FY2025
PODD Revenue••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••$1.1B$1.3B$1.7B$2.1B$2.7B
BAX Revenue••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••$12.1B$10.1B$10.4B$10.6B$11.2B

More on PODD

More on BAX

Other comparisons